Why Chemours Plunged on Wednesday

Shares of Chemours (NYSE: CC) plunged on Wednesday, falling 18.7% on the day.

The chemicals giant fell after reporting second-quarter earnings last night. Chemours had garnered some enthusiasm as a beneficiary of the AI build-out in certain end-market segments, with the stock having more than doubled earlier in 2026; however, those segments are relatively small, and its main industrial end markets remain uneven.

Thus, it's no surprise to see the stock falling hard after disappointing Q2 results.

Chemours' uneven industrial exposure

In Q2, Chemours saw a slight decline in revenue, missing analysts' expectations, while adjusted (non-GAAP) earnings per share fell 31% to $0.42, meeting Wall Street's expectations.

The primary culprit behind the lackluster performance was lower sales of the company's newer Optane refrigerants, which have lower GWP (Global Warming Potential) than older refrigerants. Residential air conditioning units designed for these new refrigerants were just introduced in 2025, as older refrigerants were banned from new equipment. This spurred Chemours to sell a lot of the new Opteon refrigerants into the channel last year. In the second quarter, sales in that segment declined because there was already a large amount of new refrigerant inventory in the supply chain. So, Chemours is suffering from a difficult comparison.

Additionally, Chemours wound down its SPS Capstone business in the third quarter of last year due to shifting regulations for those older materials. Hence, the absence of that business line also hurt year-over-year revenue.

On the positive side, Chemours has product lines in its Performance Solutions segment that target artificial intelligence data centers, including cooling fluids, specialty materials for semiconductor manufacturing, and materials for new energy applications. However, it doesn't appear that growth in those products was sufficient to offset declines in its larger segments.

Image source: Getty Images.

A potential upside case

Despite the slight revenue decline in the quarter, Chemours management still forecasts overall growth of 1% to 5% for the full year. In the second half, the company will "lap" the SPS Capstone business closing, and Chemours has also recently raised prices on several products and materials that will flow through in the second half.

Additionally, Chemours is directing its research and development efforts toward the burgeoning data center business. So as that line grows and becomes a larger part of the business, it could underpin growth looking ahead.

While the company does have a significant debt load to pay down, Chemours did generate free cash flow, and the chemicals stock now trades at just 11 times this year's adjusted earnings estimates after today's big pullback. Thus, value investors may want to have a look at the stock on this sell-off.

Billy Duberstein and/or his clients have no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.